In the full year to December 31 Prophase sales were down about 27% on the previous 12 months.You would think that this would put some urgency into OTC product development
POH shares in Prophase are treated as cash equivalent by POH and this asset is losing value with product delays.
- Forums
- ASX - By Stock
- prophase financials
AVE
avecho biotechnology limited
Add to My Watchlist
11.1%
!
0.5¢

In the full year to December 31 Prophase sales were down about...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $15.86M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $505 | 101.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 11398900 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 20942354 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 11398900 | 0.004 |
38 | 32975449 | 0.003 |
15 | 16879866 | 0.002 |
15 | 57221222 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 20942354 | 24 |
0.006 | 31685000 | 5 |
0.007 | 4498187 | 12 |
0.008 | 3472624 | 5 |
0.009 | 560000 | 2 |
Last trade - 15.50pm 14/07/2025 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |